ID   DDR1_HUMAN              Reviewed;         913 AA.
AC   Q08345; B5A975; B5A976; Q14196; Q16562; Q2L6H3; Q4LE50; Q5ST11;
AC   Q5ST12; Q6NSK4; Q9UD35; Q9UD36; Q9UD37; Q9UD86; Q9UDL2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   05-OCT-2010, entry version 125.
DE   RecName: Full=Epithelial discoidin domain-containing receptor 1;
DE            Short=Epithelial discoidin domain receptor 1;
DE            EC=2.7.10.1;
DE   AltName: Full=CD167 antigen-like family member A;
DE   AltName: Full=Cell adhesion kinase;
DE   AltName: Full=Discoidin receptor tyrosine kinase;
DE   AltName: Full=HGK2;
DE   AltName: Full=Mammary carcinoma kinase 10;
DE            Short=MCK-10;
DE   AltName: Full=Protein-tyrosine kinase 3A;
DE   AltName: Full=Protein-tyrosine kinase RTK-6;
DE   AltName: Full=TRK E;
DE   AltName: Full=Tyrosine kinase DDR;
DE   AltName: Full=Tyrosine-protein kinase CAK;
DE   AltName: CD_antigen=CD167a;
DE   Flags: Precursor;
GN   Name=DDR1; Synonyms=CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Keratinocyte;
RX   MEDLINE=94043265; PubMed=8226977;
RA   di Marco E., Cutuli N., Guerra L., Cancedda R., de Luca M.;
RT   "Molecular cloning of trkE, a novel trk-related putative tyrosine
RT   kinase receptor isolated from normal human keratinocytes and widely
RT   expressed by normal human tissues.";
RL   J. Biol. Chem. 268:24290-24295(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-833.
RC   TISSUE=Placenta;
RX   MEDLINE=93296201; PubMed=8390675; DOI=10.1073/pnas.90.12.5677;
RA   Johnson J.D., Edman J.C., Rutter W.J.;
RT   "A receptor tyrosine kinase found in breast carcinoma cells has an
RT   extracellular discoidin I-like domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5677-5681(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Ovary;
RX   MEDLINE=95151638; PubMed=7848919;
RA   Laval S., Butler R., Shelling A.N., Hanby A.M., Poulsom R.,
RA   Ganesan T.S.;
RT   "Isolation and characterization of an epithelial-specific receptor
RT   tyrosine kinase from an ovarian cancer cell line.";
RL   Cell Growth Differ. 5:1173-1183(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   MEDLINE=94134417; PubMed=8302582;
RA   Perez J.L., Shen X., Finkernagel S., Sciorra L., Jenkins N.A.,
RA   Gilbert D.J., Copeland N.G., Wong T.W.;
RT   "Identification and chromosomal mapping of a receptor tyrosine kinase
RT   with a putative phospholipid binding sequence in its ectodomain.";
RL   Oncogene 9:211-219(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-833.
RX   MEDLINE=97131588; PubMed=8977099; DOI=10.1016/S0014-5793(96)01234-3;
RA   Sakuma S., Tada M., Saya H., Sawamura Y., Shinohe Y., Abe H.;
RT   "Receptor protein tyrosine kinase DDR is up-regulated by p53
RT   protein.";
RL   FEBS Lett. 398:165-169(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=96389017; PubMed=8796349;
RA   Playford M.P., Butler R.J., Wang X.C., Katso R.M., Cooke I.E.,
RA   Ganesan T.S.;
RT   "The genomic structure of discoidin receptor tyrosine kinase.";
RL   Genome Res. 6:620-627(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   MEDLINE=96204002; PubMed=8622863;
RA   Perez J.L., Jing S.Q., Wong T.W.;
RT   "Identification of two isoforms of the Cak receptor kinase that are
RT   coexpressed in breast tumor cell lines.";
RL   Oncogene 12:1469-1477(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 1-286 (ISOFORMS 1/2/4).
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=16702430; DOI=10.1534/genetics.106.057034;
RA   Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M.,
RA   Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K.,
RA   Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y.,
RA   Meyer A., Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K.,
RA   Gojobori T., Inoko H., Bahram S.;
RT   "Rapid evolution of major histocompatibility complex class I genes in
RT   primates generates new disease alleles in humans via hitchhiking
RT   diversity.";
RL   Genetics 173:1555-1570(2006).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 501-550 (ISOFORMS 1/4), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 501-550 AND 651-694 (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 651-694 (ISOFORM 4), ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Mammary carcinoma;
RX   MEDLINE=95148233; PubMed=7845687;
RA   Alves F., Vogel W., Mossie K., Millauer B., Hoefler H., Ullrich A.;
RT   "Distinct structural characteristics of discoidin I subfamily receptor
RT   tyrosine kinases and complementary expression in human cancer.";
RL   Oncogene 10:609-618(1995).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 771-824 (ISOFORMS 1/2/4).
RX   MEDLINE=95136019; PubMed=7834423; DOI=10.1007/BF02303537;
RA   Weiner T.M., Liu E.T., Craven R.J., Cance W.G.;
RT   "Expression of growth factor receptors, the focal adhesion kinase, and
RT   other tyrosine kinases in human soft tissue tumors.";
RL   Ann. Surg. Oncol. 1:18-27(1994).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 772-823 (ISOFORMS 1/2/4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Melanocyte;
RX   MEDLINE=94067791; PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-792; TYR-796 AND
RP   TYR-797, AND MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [19]
RP   INTERACTION WITH WWC1 AND PRKCZ.
RX   PubMed=18190796; DOI=10.1016/j.bbamcr.2007.12.007;
RA   Hilton H.N., Stanford P.M., Harris J., Oakes S.R., Kaplan W.,
RA   Daly R.J., Ormandy C.J.;
RT   "KIBRA interacts with discoidin domain receptor 1 to modulate
RT   collagen-induced signalling.";
RL   Biochim. Biophys. Acta 1783:383-393(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-17; ALA-100; GLN-169; ASP-170;
RP   TRP-306 AND ALA-496.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be involved in cell-cell interactions and
CC       recognition.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts (via PPxY motif) with WWC1 (via WW domains) in
CC       a collagen-regulated manner. Forms a tripartite complex with WWC1
CC       and PRKCZ, but predominantly in the absence of collagen.
CC   -!- INTERACTION:
CC       P35568:IRS1; NbExp=1; IntAct=EBI-711879, EBI-517592;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Secreted (Potential).
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Membrane; Single-pass type I
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=CAK I;
CC         IsoId=Q08345-1; Sequence=Displayed;
CC       Name=2; Synonyms=CAK II, Short;
CC         IsoId=Q08345-2; Sequence=VSP_002953;
CC       Name=3;
CC         IsoId=Q08345-4; Sequence=VSP_036916, VSP_036917;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC       Name=4;
CC         IsoId=Q08345-5; Sequence=VSP_038057;
CC   -!- TISSUE SPECIFICITY: Detected in T-47D, MDA-MB-175 and HBL-100
CC       breast carcinoma cells, A431 epidermoid carcinoma cells, SW48 and
CC       SNU-C2B colon carcinoma cells and Hs 294T melanoma cells (at
CC       protein level). Expressed at low levels in most adult tissues and
CC       is highest in the brain, lung, placenta and kidney. Lower levels
CC       of expression are detected in melanocytes, heart, liver, skeletal
CC       muscle and pancreas. Abundant in breast carcinoma cell lines. In
CC       the colonic mucosa, expressed in epithelia but not in the
CC       connective tissue of the lamina propria. In the thyroid gland,
CC       expressed in the epithelium of the thyroid follicles. In pancreas,
CC       expressed in the islets of Langerhans cells, but not in the
CC       surrounding epithelial cells of the exocrine pancreas. In kidney,
CC       expressed in the epithelia of the distal tubules. Not expressed in
CC       connective tissue, endothelial cells, adipose tissue, muscle cells
CC       or cells of hematopoietic origin.
CC   -!- DOMAIN: The Gly/Pro-rich domains may be required for an unusual
CC       geometry of interaction with ligand or substrates.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC   -!- SIMILARITY: Contains 1 F5/8 type C domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ACF47649.1; Type=Erroneous termination; Positions=287; Note=Translated as Cys;
CC       Sequence=BAE06103.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74979; CAA52915.1; -; mRNA.
DR   EMBL; L11315; AAA02866.1; -; mRNA.
DR   EMBL; Z29093; CAA82335.1; -; mRNA.
DR   EMBL; L20817; AAA18019.1; -; mRNA.
DR   EMBL; U48705; AAC50917.1; -; Genomic_DNA.
DR   EMBL; X98208; CAA66871.1; -; Genomic_DNA.
DR   EMBL; X99023; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99024; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99025; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99026; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99027; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99028; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99029; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99030; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99031; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99032; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99033; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; X99034; CAA66871.1; JOINED; Genomic_DNA.
DR   EMBL; L57508; AAB05208.1; -; mRNA.
DR   EMBL; EU826613; ACF47649.1; ALT_SEQ; mRNA.
DR   EMBL; EU826614; ACF47650.1; -; mRNA.
DR   EMBL; AK291621; BAF84310.1; -; mRNA.
DR   EMBL; AB210021; BAE06103.1; ALT_INIT; mRNA.
DR   EMBL; BA000025; BAB63318.1; -; Genomic_DNA.
DR   EMBL; CR759747; CAQ06757.1; -; Genomic_DNA.
DR   EMBL; CR759747; CAQ06756.1; -; Genomic_DNA.
DR   EMBL; AB088102; BAC54935.1; -; Genomic_DNA.
DR   EMBL; AB103608; BAF31270.1; -; Genomic_DNA.
DR   EMBL; AL662854; CAI17434.1; -; Genomic_DNA.
DR   EMBL; AL662870; CAI18441.1; -; Genomic_DNA.
DR   EMBL; AL773541; CAI18450.1; -; Genomic_DNA.
DR   EMBL; AL773589; CAI18450.1; JOINED; Genomic_DNA.
DR   EMBL; AL773589; CAI18534.1; -; Genomic_DNA.
DR   EMBL; AL773541; CAI18534.1; JOINED; Genomic_DNA.
DR   EMBL; AL662854; CAI17433.1; -; Genomic_DNA.
DR   EMBL; AL662870; CAI18442.1; -; Genomic_DNA.
DR   EMBL; AL773541; CAI18451.1; -; Genomic_DNA.
DR   EMBL; AL773589; CAI18451.1; JOINED; Genomic_DNA.
DR   EMBL; AL773589; CAI18533.1; -; Genomic_DNA.
DR   EMBL; AL773541; CAI18533.1; JOINED; Genomic_DNA.
DR   EMBL; AB202100; BAE78621.1; -; Genomic_DNA.
DR   EMBL; BX927194; CAQ09768.1; -; Genomic_DNA.
DR   EMBL; BX927194; CAQ09767.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03335.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03338.1; -; Genomic_DNA.
DR   EMBL; BC008716; AAH08716.1; -; mRNA.
DR   EMBL; BC013400; AAH13400.1; -; mRNA.
DR   EMBL; BC070070; AAH70070.1; -; mRNA.
DR   IPI; IPI00001477; -.
DR   IPI; IPI00219996; -.
DR   IPI; IPI00657861; -.
DR   IPI; IPI00910318; -.
DR   PIR; A48280; A48280.
DR   PIR; A49508; A49508.
DR   RefSeq; NP_001945.3; -.
DR   RefSeq; NP_054699.2; -.
DR   RefSeq; NP_054700.2; -.
DR   UniGene; Hs.631988; -.
DR   ProteinModelPortal; Q08345; -.
DR   SMR; Q08345; 27-186, 43-273.
DR   IntAct; Q08345; 18.
DR   MINT; MINT-1383336; -.
DR   STRING; Q08345; -.
DR   PhosphoSite; Q08345; -.
DR   PRIDE; Q08345; -.
DR   Ensembl; ENST00000324771; ENSP00000318217; ENSG00000204580.
DR   Ensembl; ENST00000376568; ENSP00000365752; ENSG00000204580.
DR   Ensembl; ENST00000376575; ENSP00000365759; ENSG00000204580.
DR   Ensembl; ENST00000383377; ENSP00000372868; ENSG00000137332.
DR   Ensembl; ENST00000400414; ENSP00000383265; ENSG00000137332.
DR   Ensembl; ENST00000400491; ENSP00000383338; ENSG00000215522.
DR   Ensembl; ENST00000400492; ENSP00000383339; ENSG00000215522.
DR   Ensembl; ENST00000412329; ENSP00000391805; ENSG00000230456.
DR   Ensembl; ENST00000416487; ENSP00000408328; ENSG00000137332.
DR   Ensembl; ENST00000418800; ENSP00000407699; ENSG00000204580.
DR   Ensembl; ENST00000423471; ENSP00000410595; ENSG00000230456.
DR   Ensembl; ENST00000429699; ENSP00000401397; ENSG00000234078.
DR   Ensembl; ENST00000430933; ENSP00000397769; ENSG00000234078.
DR   Ensembl; ENST00000433150; ENSP00000390639; ENSG00000137332.
DR   Ensembl; ENST00000434105; ENSP00000402809; ENSG00000230456.
DR   Ensembl; ENST00000437664; ENSP00000396553; ENSG00000234078.
DR   Ensembl; ENST00000437788; ENSP00000408684; ENSG00000137332.
DR   Ensembl; ENST00000442337; ENSP00000406772; ENSG00000215522.
DR   Ensembl; ENST00000442451; ENSP00000393085; ENSG00000215522.
DR   Ensembl; ENST00000442511; ENSP00000393389; ENSG00000215522.
DR   Ensembl; ENST00000444953; ENSP00000397716; ENSG00000137332.
DR   Ensembl; ENST00000446697; ENSP00000405579; ENSG00000234078.
DR   Ensembl; ENST00000449518; ENSP00000414285; ENSG00000230456.
DR   Ensembl; ENST00000450117; ENSP00000396139; ENSG00000215522.
DR   Ensembl; ENST00000451372; ENSP00000409630; ENSG00000230456.
DR   Ensembl; ENST00000452093; ENSP00000398339; ENSG00000230456.
DR   Ensembl; ENST00000452441; ENSP00000405039; ENSG00000204580.
DR   Ensembl; ENST00000454096; ENSP00000407930; ENSG00000234078.
DR   Ensembl; ENST00000454612; ENSP00000406091; ENSG00000204580.
DR   GeneID; 780; -.
DR   KEGG; hsa:780; -.
DR   UCSC; uc003nrr.1; human.
DR   CTD; 780; -.
DR   GeneCards; GC06P030848; -.
DR   HGNC; HGNC:2730; DDR1.
DR   HPA; CAB010162; -.
DR   HPA; CAB025656; -.
DR   MIM; 600408; gene.
DR   PharmGKB; PA24348; -.
DR   HOVERGEN; HBG005461; -.
DR   InParanoid; Q08345; -.
DR   OMA; CPLGLYE; -.
DR   OrthoDB; EOG9X9B2Z; -.
DR   BRENDA; 2.7.10.1; 247.
DR   DrugBank; DB00619; Imatinib.
DR   NextBio; 3152; -.
DR   PMAP-CutDB; Q08345; -.
DR   CleanEx; HS_DDR1; -.
DR   Genevestigator; Q08345; -.
DR   GermOnline; ENSG00000204580; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR000421; Coagulation_factor_5/8-type_C.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020742; Tyr_kin_discoidin-contain_rcpt.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR002011; Tyr_prot_kinase_rcpt_2_CS.
DR   PANTHER; PTHR23256:SF253; Tyr_kin_discoidin-contain_rcpt; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Disulfide bond;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Secreted; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     18       Potential.
FT   CHAIN        19    913       Epithelial discoidin domain-containing
FT                                receptor 1.
FT                                /FTId=PRO_0000016742.
FT   TOPO_DOM     19    416       Extracellular (Potential).
FT   TRANSMEM    417    443       Helical; (Potential).
FT   TOPO_DOM    444    913       Cytoplasmic (Potential).
FT   DOMAIN       31    185       F5/8 type C.
FT   DOMAIN      610    905       Protein kinase.
FT   NP_BIND     616    624       ATP (By similarity).
FT   MOTIF       481    484       PPxY motif.
FT   COMPBIAS    377    415       Gly/Pro-rich.
FT   COMPBIAS    476    601       Gly/Pro-rich.
FT   ACT_SITE    766    766       Proton acceptor (By similarity).
FT   BINDING     655    655       ATP (By similarity).
FT   MOD_RES     513    513       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     631    631       Phosphoserine.
FT   MOD_RES     792    792       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     796    796       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     797    797       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    211    211       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    260    260       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    371    371       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    394    394       N-linked (GlcNAc...) (Potential).
FT   DISULFID     31    185       By similarity.
FT   VAR_SEQ     190    243       GLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQ
FT                                LADGVVGLDDFRK -> CSMGVWASWQMVWWGWMTLGRVRS
FT                                CGSGQAMTMWDGATTASPVAMWRWSLSLTG (in
FT                                isoform 3).
FT                                /FTId=VSP_036916.
FT   VAR_SEQ     244    913       Missing (in isoform 3).
FT                                /FTId=VSP_036917.
FT   VAR_SEQ     506    542       Missing (in isoform 2).
FT                                /FTId=VSP_002953.
FT   VAR_SEQ     665    665       A -> ASFSLFS (in isoform 4).
FT                                /FTId=VSP_038057.
FT   VARIANT      17     17       S -> G (in dbSNP:rs55901302).
FT                                /FTId=VAR_041492.
FT   VARIANT     100    100       V -> A (in dbSNP:rs34544756).
FT                                /FTId=VAR_041493.
FT   VARIANT     169    169       R -> Q (in dbSNP:rs55980643).
FT                                /FTId=VAR_041494.
FT   VARIANT     170    170       A -> D (in dbSNP:rs56231803).
FT                                /FTId=VAR_041495.
FT   VARIANT     306    306       R -> W (in dbSNP:rs56024191).
FT                                /FTId=VAR_041496.
FT   VARIANT     496    496       S -> A (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041497.
FT   VARIANT     833    833       L -> V (in dbSNP:rs2524235).
FT                                /FTId=VAR_049716.
FT   CONFLICT     94     94       L -> V (in Ref. 2; AAA02866 and 5;
FT                                AAC50917).
FT   CONFLICT    165    165       R -> H (in Ref. 14; AAH70070).
FT   CONFLICT    285    286       VH -> MW (in Ref. 8; ACF47649).
FT   CONFLICT    741    741       P -> Q (in Ref. 14; AAH70070).
FT   CONFLICT    847    867       QLTDEQVIENAGEFFRDQGRQ -> SAHRRAGHRERGGVLP
FT                                GPGPA (in Ref. 6; CAA66871).
SQ   SEQUENCE   913 AA;  101128 MW;  C96913EA906C481E CRC64;
     MGPEALSSLL LLLLVASGDA DMKGHFDPAK CRYALGMQDR TIPDSDISAS SSWSDSTAAR
     HSRLESSDGD GAWCPAGSVF PKEEEYLQVD LQRLHLVALV GTQGRHAGGL GKEFSRSYRL
     RYSRDGRRWM GWKDRWGQEV ISGNEDPEGV VLKDLGPPMV ARLVRFYPRA DRVMSVCLRV
     ELYGCLWRDG LLSYTAPVGQ TMYLSEAVYL NDSTYDGHTV GGLQYGGLGQ LADGVVGLDD
     FRKSQELRVW PGYDYVGWSN HSFSSGYVEM EFEFDRLRAF QAMQVHCNNM HTLGARLPGG
     VECRFRRGPA MAWEGEPMRH NLGGNLGDPR ARAVSVPLGG RVARFLQCRF LFAGPWLLFS
     EISFISDVVN NSSPALGGTF PPAPWWPPGP PPTNFSSLEL EPRGQQPVAK AEGSPTAILI
     GCLVAIILLL LLIIALMLWR LHWRRLLSKA ERRVLEEELT VHLSVPGDTI LINNRPGPRE
     PPPYQEPRPR GNPPHSAPCV PNGSALLLSN PAYRLLLATY ARPPRGPGPP TPAWAKPTNT
     QAYSGDYMEP EKPGAPLLPP PPQNSVPHYA EADIVTLQGV TGGNTYAVPA LPPGAVGDGP
     PRVDFPRSRL RFKEKLGEGQ FGEVHLCEVD SPQDLVSLDF PLNVRKGHPL LVAVKILRPD
     ATKNARNDFL KEVKIMSRLK DPNIIRLLGV CVQDDPLCMI TDYMENGDLN QFLSAHQLED
     KAAEGAPGDG QAAQGPTISY PMLLHVAAQI ASGMRYLATL NFVHRDLATR NCLVGENFTI
     KIADFGMSRN LYAGDYYRVQ GRAVLPIRWM AWECILMGKF TTASDVWAFG VTLWEVLMLC
     RAQPFGQLTD EQVIENAGEF FRDQGRQVYL SRPPACPQGL YELMLRCWSR ESEQRPPFSQ
     LHRFLAEDAL NTV
//
